Can surgery extend life in advanced pancreatic NET? major trial launches

NCT ID NCT07273409

First seen Jan 11, 2026 · Last updated May 16, 2026 · Updated 16 times

Summary

This study looks at whether removing most of the visible tumors (debulking surgery) in people with stage 4 pancreatic neuroendocrine tumors (pan-NET) can help them live longer and feel better compared to standard medical treatments alone. About 200 adults with slow-growing, advanced pan-NET will be randomly assigned to receive either surgery plus usual care or usual care alone. The goal is to see if surgery improves survival, quality of life, and reduces hospital visits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC NEUROENDOCRINE TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Karolinska University Hospital

    RECRUITING

    Stockholm, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Sahlgrenska University Hospital

    RECRUITING

    Gothenburg, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Skåne University Hospital

    NOT_YET_RECRUITING

    Lund, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Uppsala University Hospital

    RECRUITING

    Uppsala, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.